Haorui Pharma-Chem Inc.

About Haorui Products Technology Contact
 
API Index
 
A
Adapalene
Alfuzosin HCl
  Altrenogest 
  Amifostine
  5-Aminolevulinic acid 
  Amisulpride
  Amlexanox
  Amorolfine HCl   
  Anastrozole 
  Ascomycin (FK520)
  Atracurium besylate
  Azelastine HCl
  Aztreonam
  B
  Benidipine HCl 
  Bicalutamide
  Brimonidine tartrate
  C
  Camptothecin
  Candesartan cilexetil 
  Capecitabine
  D
  Daptomycin
  Dasatinib
  Desogestrel
  Dexrazoxane 
  Dirithromycin
  Dipeptiven
  Docetaxel
  Dofetilide
  Dolasetron mesylate
  Donepezil HCl
  Doramectin
  Doxazosin mesylate
  Drospirenone
  E
  Entecavir
  Epalrestat
  Eplerenone
  Epinastine HCl
  Eplerenone
  Erlotinib HCl
  Erythromycin ethylsuccinate
  Escitalopram oxalate
  Estradiol
  Estradiol Benzoate
  Estriol
  Ethinyl Estradiol
  Everolimus
  Exemestane
  Everolimus
  F
  Fipronil
  Fludarabine phosphate
  Flumazenil
  Fluvastatin sodium
  G
  Gefitinib
  Gemcitabine HCl
  Gestodene
  Gestrinone
  Glimepiride
  Granisetron HCl
  H
  10-hydroxycamptothecin
  I
  Ibandronate sodium
  Ibutilide fumarate
  Imatinib mesylate
  Imipenem + Cilastatin sodium 
  Irbesartan 
  Irinotecan HCl 
  L
  Latanoprost
  Lenalidomide
  Letrozole
  Levetiracetam
  Levofloxacin 
  Levonorgestrel 
  Linezolid
  Lymecycline
  Lynoestrenol 
  M
  Maraviroc
  Melengestrol acetate
  Memantine HCl   
  Meropenem  
  Mestranol
  Methazolamide
  Mifepristone 
  Midazolam
  Miglitol 
  Mitoxantrone HCl
  Mizolastine HCl 
  Mofegiline HCl
  Mosapride citrate
  Moxidectin
  Mupirocin
  N
  N(2)-L-alanyl-L-glutamine
  Nandrolone phenylpropionate
  Nabumetone
  Natamycin
  Nebivolol
  Nedaplatin
  Nilutamide
  Norelgestromin 
  Norgestimate
  O
  Olanzapine
  Orlistat 
  Oxaliplatin 
  P
  Paclitaxel
  Palonosetron
  Pamidronate disodium
  Pemetrexed disodium
  Pemirolast potassium
  Polymyxin B sulfate
  Pramipexole 2HCl 
  Pranlukast hydrate
  R
  Racecadotril
  Rilmenidine
  Ramosetron
  Ranolazine
  Rapamycin (Sirolimus) 
  Rebamipide 
  Retigabine
  Rifaximine
  Rilmenidine  
  Riluzole 
  Risedronate sodium
  Rizatriptan benzoate
  Ropinirole
  Ropivacaine HCL
  S
  Sirolimus (Rapamycin) 
  Sorafenib tosylate
  Sunitinib malate
  T
  Tacrolimus (FK506) 
  Tamsulosin HCl 
  Tazobactam+Piperacillin 
  Teicoplanin
  Telmisartan 
  Temozolomide 
  Terazosin HCl
  Tibolone
  Tigecycline
  Topotecan HCl
  Travoprost
  Trenbolone Acetate
  Trimegestone
  Tropisetron HCL
  V
  Valsartan 
  Valrubicin 
  Vancomycin HCl
  Vecuronium bromide
  Venlafaxine HCl   
  Vinorelbine tartrate
  Voglibose
  Voriconazole
  Z
  Zanamivir
  Zoledronic acid
  Zolmitriptan
  Zonisamide

 
Haorui supplies Amifostine API (Active Pharmaceutical Ingredient) to pharmaceutical industry.  Haorui's Amifostine API is produced by FDA approved cGMP facilities, we supply Amifostine API from small R&D to large commercial quantity. For product and supply details please contact us.
Amifostine Clinical Trials 2

Amifostine Clinical Trials 1       Amifostine Clinical Trials 2
Amifostine Patents 1               Amifostine Patents 2                 Amifostine Patents 3
Amifostine Patents 4               Amifostine Patents 5
51   Active, not recruiting   Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Conditions:   Head and Neck Cancer;   Oral Complications of Cancer and Cancer Therapy
Interventions:   Drug: amifostine trihydrate;   Drug: paclitaxel;   Procedure: chemoprotection;   Procedure: chemotherapy;   Procedure: conventional surgery;   Procedure: radiation therapy
 
52   Active, not recruiting   Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer
Condition:   Colorectal Cancer
Interventions:   Drug: amifostine trihydrate;   Drug: irinotecan hydrochloride;   Procedure: chemoprotection;   Procedure: chemotherapy
 
53   Terminated   Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer
Condition:   Cervical Cancer
Interventions:   Procedure: Radiation Therapy;   Drug: Cisplatin;   Drug: Amifostine
 
54   Active, not recruiting   Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-Small Cell Lung Cancer
Conditions:   Lung Cancer;   Neurotoxicity;   Ovarian Cancer
Interventions:   Drug: amifostine trihydrate;   Drug: carboplatin;   Drug: paclitaxel;   Procedure: chemotherapy;   Procedure: neurotoxicity attenuation
 
55   Recruiting   Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
Conditions:   Head and Neck Cancer;   Oral Complications of Chemotherapy and Head/Neck Radiation
Interventions:   Drug: amifostine trihydrate;   Drug: cisplatin;   Drug: fluorouracil;   Procedure: chemotherapy;   Procedure: management of therapy complications;   Procedure: neoadjuvant therapy;   Procedure: radiation therapy;   Procedure: radioprotection
 
56   Active, not recruiting   Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy
Conditions:   Drug Toxicity;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions:   Drug: amifostine trihydrate;   Drug: cisplatin;   Drug: irinotecan hydrochloride;   Procedure: chemoprotection;   Procedure: chemotherapy
 
57   Active, not recruiting   Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome
Conditions:   Leukemia;   Myelodysplastic Syndromes
Interventions:   Drug: amifostine trihydrate;   Drug: cytarabine;   Drug: topotecan hydrochloride;   Procedure: chemoprotection;   Procedure: chemotherapy
 
58   Completed   Intravenous Versus Subcutaneous Amifostine in Prevention of Xerostomia After RT for Head and Neck Carcinomas
Condition:   Head and Neck Cancer
Intervention:   Drug: Ethyol
 
59   Active, not recruiting   High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation and Chemoprotective Therapy in Treating Patients With Cancer
Conditions:   Breast Cancer;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Neuroblastoma;   Ovarian Cancer;   Sarcoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions:   Drug: amifostine trihydrate;   Drug: cyclophosphamide;   Drug: filgrastim;   Drug: melphalan;   Procedure: chemoprotection;   Procedure: chemotherapy;   Procedure: peripheral blood stem cell transplantation
 
60   Active, not recruiting   Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer
Condition:   Head and Neck Cancer
Intervention:   Drug: Ethyol (drug)
 
61   Recruiting   Phase III of Unilateral Neck Irradiation With Amifostine in Patients With SCC of the Head and Neck
Condition:   Squamous Cell Carcinoma of the Head and Neck
Intervention:   Drug: Ethyol
 
62   Active, not recruiting   Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia
Condition:   Fanconi's Anemia
Intervention:   Drug: amifostine
 
63   Active, not recruiting   High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer
Conditions:   Breast Cancer;   Drug Toxicity
Interventions:   Drug: amifostine trihydrate;   Drug: cyclophosphamide;   Drug: mitoxantrone hydrochloride;   Drug: thiotepa;   Procedure: chemoprotection;   Procedure: chemotherapy;   Procedure: peripheral blood stem cell transplantation
 
64   Active, not recruiting   Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer
Conditions:   Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions:   Drug: amifostine trihydrate;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: filgrastim;   Procedure: chemoprotection;   Procedure: chemotherapy;   Procedure: colony-stimulating factor therapy;   Procedure: peripheral blood stem cell transplantation
 
65   Active, not recruiting   Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer
Condition:   Endometrial Cancer
Interventions:   Drug: amifostine trihydrate;   Drug: carboplatin;   Drug: paclitaxel;   Procedure: chemotherapy
 
66   Completed   Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Conditions:   Drug Toxicity;   Lung Cancer;   Radiation Toxicity
Interventions:   Drug: amifostine trihydrate;   Drug: cisplatin;   Drug: etoposide;   Drug: filgrastim;   Drug: paclitaxel;   Drug: topotecan hydrochloride;   Procedure: chemoprotection;   Procedure: chemotherapy;   Procedure: colony-stimulating factor therapy;   Procedure: radiation therapy;   Procedure: radioprotection
 
67   Active, not recruiting   Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
Condition:   Leukemia
Interventions:   Drug: amifostine trihydrate;   Drug: bromodeoxyuridine;   Drug: cytarabine;   Drug: idarubicin;   Drug: idoxuridine;   Drug: isotretinoin;   Drug: mitoxantrone hydrochloride;   Drug: recombinant interferon alfa;   Procedure: chemotherapy;   Procedure: interferon therapy
 
68   Active, not recruiting   Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer
Condition:   Head and Neck Cancer
Interventions:   Drug: amifostine trihydrate;   Drug: cisplatin;   Drug: fluorouracil;   Procedure: chemoprotection;   Procedure: chemotherapy;   Procedure: radiation therapy;   Procedure: radioprotection;   Procedure: surgical procedure
 
69   Active, not recruiting   Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate
Conditions:   Pleural Mesothelioma;   Malignant Pleural Mesothelioma
Interventions:   Drug: Cisplatin;   Drug: Sodium Thiosulfate
 
70   Completed   Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck
Conditions:   Cancer of Head and Neck;   Head Cancer;   Head and Neck Cancer;   Neck Cancer;   Neck Neoplasms
Interventions:   Drug: Cisplatin;   Drug: Docetaxel;   Procedure: Radiotherapy
 
71   Active, not recruiting   Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer
Condition:   Liver Cancer
Interventions:   Drug: cisplatin;   Drug: fluorouracil;   Drug: vincristine;   Procedure: adjuvant therapy;   Procedure: chemotherapy;   Procedure: conventional surgery
 
72   Completed   Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
Condition:   Brain and Central Nervous System Tumors
Interventions:   Drug: amifostine trihydrate;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: filgrastim;   Drug: vincristine;   Procedure: chemoprotection;   Procedure: chemotherapy;   Procedure: colony-stimulating factor therapy;   Procedure: peripheral blood stem cell transplantation;   Procedure: radiation therapy;   Procedure: radioprotection
 
73   Completed   Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor
Conditions:   Neutropenia;   Sarcoma
Interventions:   Drug: amifostine trihydrate;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: filgrastim;   Drug: ifosfamide;   Drug: topotecan hydrochloride;   Drug: vincristine;   Procedure: chemotherapy;   Procedure: colony-stimulating factor therapy;   Procedure: conventional surgery;   Procedure: low-LET cobalt-60 gamma ray therapy;   Procedure: low-LET electron therapy;   Procedure: low-LET photon therapy
 
74   Active, not recruiting   Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
Condition:   Lung Cancer
Interventions:   Drug: carboplatin;   Drug: paclitaxel;   Procedure: chemotherapy;   Procedure: radiation therapy

 

Haorui - Your Partner to Pharmaceutical Success - Copy Right Reserved